MicroRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer

Molecular Cancer

Volumn 13, Issue 1, 2014, Pages

  Zhang, Lijing ^a,b   Dong, Yujuan ^a,c   Zhu, Nana ^a,b   Tsoi, Ho ^a   Zhao, Zengren ^b   Wu, Chung W ^a   Wang, Kunning ^a   Zheng, Shu ^d   Ng, Simon S M ^b   Chan, Francis K L ^a   Sung, Joseph J Y ^a   Yu, Jun ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b HEBEI MEDICAL UNIVERSITY   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Colorectal cancer; MiR 139 5p; NOTCH1; Tumor suppressor

Indexed keywords

CASPASE 3; CASPASE 7; CASPASE 8; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; GELATINASE B; MATRILYSIN; MICRORNA; MICRORNA 139 5P; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NOTCH1 RECEPTOR; UNCLASSIFIED DRUG; MIRN139 MICRORNA, HUMAN; NOTCH1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL LINE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL VIABILITY; COLONY FORMATION; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; ENZYME INDUCTION; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUCIFERASE ASSAY; MIGRATION INHIBITION; MOUSE; NONHUMAN; PROTEIN RNA BINDING; SIGNAL TRANSDUCTION; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; COLORECTAL TUMOR; DRUG SCREENING; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; PATHOLOGY; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

MUS MUSCULUS;

ANIMALS; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENES, TUMOR SUPPRESSOR; HUMANS; MICE; MICRORNAS; RECEPTOR, NOTCH1; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84904720607     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-13-124     Document Type: Article

References (46)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127:2893-2917. 10.1002/ijc.25516, 21351269.
2. Sung JJ, Lau JY, Goh KL, Leung WK. Asia Pacific working group on colorectal cancer. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol 2005, 6:871-876. 10.1016/S1470-2045(05)70422-8, 16257795.
3. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006, 6:857-866. 10.1038/nrc1997, 17060945.
4. Croce CM. Oncogenes and cancer. N Engl J Med 2008, 358:502-511. 10.1056/NEJMra072367, 18234754.
5. Deng S, Calin GA, Croce CM, Coukos G, Zhang L. Mechanisms of microRNA deregulation in human cancer. Cell Cycle 2008, 7:2643-2646. 10.4161/cc.7.17.6597, 18719391.
6. Zhang N, Li X, Wu CW, Dong Y, Cai M, Mok MT, Wang H, Chen J, Ng SS, Chen M, Sung JJ, Yu J. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis. Oncogene in press.
7. He X, Dong Y, Wu CW, Zhao Z, Ng SS, Chan FK, Sung JJ, Yu J. MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene. Mol Med 2013, 18:1491-1498. 3576472, 23255074.
8. Dong Y, Zhao J, Wu CW, Zhang L, Liu X, Kang W, Leung WW, Zhang N, Chan FK, Sung JJ, Ng SS, Yu J. Tumor suppressor functions of miR-133a in colorectal cancer. Mol Cancer Res 2013, 11:1051-1060. 10.1158/1541-7786.MCR-13-0061, 23723074.
9. Wu CW, Ng SC, Dong Y, Tian L, Ng SS, Leung WW, Law WT, Yau TO, Chan FK, Sung JJY, Jun Y. Identification of microRNA-135b in stool as a potential non-invasive biomarker for colorectal cancer and adenoma. Clin Cancer Res in press.
10. Vu TH, Werb Z. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev 2000, 14:2123-2133. 10.1101/gad.815400, 10970876.
11. Zucker S, Vacirca J. Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev 2004, 23:101-117.
12. Sawey ET, Johnson JA, Crawford HC. Matrix metalloproteinase 7 controls pancreatic acinar cell transdifferentiation by activating the Notch signaling pathway. Proc Natl Acad Sci U S A 2007, 104:19327-19332. 10.1073/pnas.0705953104, 2148289, 18042722.
13. Pope JL, Bhat AA, Sharma A, Ahmad R, Krishnan M, Washington MK, Beauchamp RD, Singh AB, Dhawan P. Claudin-1 regulates intestinal epithelial homeostasis through the modulation of Notch-signalling. Gut 2014, 63:622-634. 10.1136/gutjnl-2012-304241, 23766441.
14. Olaru AV, Selaru FM, Mori Y, Vazquez C, David S, Paun B, Cheng Y, Jin Z, Yang J, Agarwal R, Abraham JM, Dassopoulos T, Harris M, Bayless TM, Kwon J, Harpaz N, Livak F, Meltzer SJ. Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformation. Inflamm Bowel Dis 2011, 17:221-231. 10.1002/ibd.21359, 3006011, 20848542.
15. Cekaite L, Rantala JK, Bruun J, Guriby M, Agesen TH, Danielsen SA, Lind GE, Nesbakken A, Kallioniemi O, Lothe RA, Skotheim RI. MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancer. Neoplasia 2012, 14:868-879. 3459282, 23019418.
16. Chang KH, Miller N, Kheirelseid EA, Lemetre C, Ball GR, Smith MJ, Regan M, McAnena OJ, Kerin MJ. MicroRNA signature analysis in colorectal cancer: identification of expression profiles in stage II tumors associated with aggressive disease. Int J Colorectal Dis 2011, 26:1415-1422. 10.1007/s00384-011-1279-4, 21739196.
17. Shen K, Liang Q, Xu K, Cui D, Jiang L, Yin P, Lu Y, Li Q, Liu J. MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor. Biochem Pharmacol 2012, 84:320-330. 10.1016/j.bcp.2012.04.017, 22580051.
18. Schepeler T, Holm A, Halvey P, Nordentoft I, Lamy P, Riising EM, Christensen LL, Thorsen K, Liebler DC, Helin K, Ørntoft TF, Andersen CL. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes. Oncogene 2012, 31:2750-2760. 10.1038/onc.2011.453, 21963845.
19. Guo J, Miao Y, Xiao B, Huan R, Jiang Z, Meng D, Wang Y. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol 2009, 24:652-657. 10.1111/j.1440-1746.2008.05666.x, 19175831.
20. Hiroki E, Akahira J, Suzuki F, Nagase S, Ito K, Suzuki T, Sasano H, Yaegashi N. Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas. Cancer Sci 2010, 101:241-249. 10.1111/j.1349-7006.2009.01385.x, 19891660.
21. Wong CC, Wong CM, Tung EK, Au SL, Lee JM, Poon RT, Man K, Ng IO. The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2. Gastroenterology 2011, 140:322-331. 10.1053/j.gastro.2010.10.006, 20951699.
22. Watanabe K, Sunohara M, Amano Y, Ishikawa R, Ichinose J, Nakajima J, Fukayama M, Yatomi Y, Nagase T, Ohishi N, Takai D. Histone methylation-mediated silencing of mir-139 enhances an aggressive phenotype of non-small cell lung cancer [abstract]. Clin Cancer Res 2014, 20:B28-B28. doi: 10.1158/1078-0432.14AACRIASLC-B28.
23. Au SL, Wong CC, Lee JM, Fan DN, Tsang FH, Ng IO, Wong CM. Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis. Hepatology 2012, 56:622-631. 10.1002/hep.25679, 22370893.
24. Bao W, Fu HJ, Xie QS, Wang L, Zhang R, Guo ZY, Zhao J, Meng YL, Ren XL, Wang T, Li Q, Jin BQ, Yao LB, Wang RA, Fan DM, Chen SY, Jia LT, Yang AG. HER2 interacts with CD44 to up-regulate CXCR4 via epigenetic silencing of microRNA-139 in gastric cancer cells. Gastroenterology 2011, 141:2076-2087. 10.1053/j.gastro.2011.08.050, 21925125.
25. Krishnan K, Steptoe AL, Martin HC, Pattabiraman DR, Nones K, Waddell N, Mariasegaram M, Simpson PT, Lakhani SR, Vlassov A, Grimmond SM, Cloonan N. miR-139-5p is a regulator of metastatic pathways in breast cancer. RNA 2013, 19:1767-1780. 10.1261/rna.042143.113, 3884652, 24158791.
26. Tokino T, Nakamura Y. The role of p53-target genes in human cancer. Crit Rev Oncol Hemat 2000, 33:1-6.
27. Cheng WL, Lin TY, Tseng YH, Chu FH, Chueh PJ, Kuo YH, Wang SY. Inhibitory effect of human breast cancer cell proliferation via p21-mediated G(1) cell cycle arrest by Araliadiol isolated from Aralia cordata Thunb. Planta Med 2011, 77:164-168. 10.1055/s-0030-1250177, 20717878.
28. Broude EV, Swift ME, Vivo C, Chang BD, Davis BM, Kalurupalle S, Blagosklonny MV, Roninson IB. p21(Waf1/Cip1/Sdi1) mediates retinoblastoma protein degradation. Oncogene 2007, 26:6954-6958. 10.1038/sj.onc.1210516, 17486059.
29. Mitrea DM, Yoon MK, Ou L, Kriwacki RW. Disorder-function relationships for the cell cycle regulatory proteins p21 and p27. Biol Chem 2012, 393:259-274.
30. Johnstone RW, Frew AJ, Smyth MJ. The TRAIL apoptotic pathway in cancer onset, progression and therapy. Nat Rev Cancer 2008, 8:782-798. 10.1038/nrc2465, 18813321.
31. Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer 2009, 9:361-371. 10.1038/nrc2628, 19343034.
32. Holoch PA, Griffith TS. TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies. Eur J Pharmacol 2009, 625:63-72. 10.1016/j.ejphar.2009.06.066, 2783837, 19836385.
33. Schutze S, Tchikov V, Schneider-Brachert W. Regulation of TNFR1 and CD95 signalling by receptor compartmentalization. Nat Rev Mol Cell Biol 2008, 9:655-662. 10.1038/nrm2430, 18545270.
34. Witty JP, McDonnell S, Newell KJ, Cannon P, Navre M, Tressler RJ, Matrisian LM. Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo. Cancer Res 1994, 54:4805-4812.
35. Yamamoto H, Itoh F, Hinoda Y, Imai K. Suppression of matrilysin inhibits colon cancer cell invasion in vitro. Int J Cancer 1995, 61:218-222. 10.1002/ijc.2910610213, 7705951.
36. van Kempen LC, Coussens LM. MMP9 potentiates pulmonary metastasis formation. Cancer Cell 2002, 2:251-252. 10.1016/S1535-6108(02)00157-5, 12398887.
37. Guo H, Hu X, Ge S, Qian G, Zhang J. Regulation of RAP1B by miR-139 suppresses human colorectal carcinoma cell proliferation. Int J Biochem Cell Biol 2012, 44:1465-1472. 10.1016/j.biocel.2012.05.015, 22642900.
38. Qiao L, Wong BC. Role of Notch signaling in colorectal cancer. Carcinogenesis 2009, 30:1979-1986. 10.1093/carcin/bgp236, 19793799.
39. Riccio O, van Gijn ME, Bezdek AC, Pellegrinet L, van Es JH, Zimber-Strobl U, Strobl LJ, Honjo T, Clevers H, Radtke F. Loss of intestinal crypt progenitor cells owing to inactivation of both Notch1 and Notch2 is accompanied by derepression of CDK inhibitors p27Kip1 and p57Kip2. EMBO Rep 2008, 9:377-383. 10.1038/embor.2008.7, 2288761, 18274550.
40. Zhang X, Chen T, Zhang J, Mao Q, Li S, Xiong W, Qiu Y, Xie Q, Ge J. Notch1 promotes glioma cell migration and invasion by stimulating β-catenin and NF-κB signaling via AKT activation. Cancer Sci 2012, 103:181-190. 10.1111/j.1349-7006.2011.02154.x, 22093097.
41. Sarmento LM, Huang H, Limon A, Gordon W, Fernandes J, Tavares MJ, Miele L, Cardoso AA, Classon M, Carlesso N. Notch1 modulates timing of G1-S progression by inducing SKP2 transcription and p27 Kip1 degradation. J Exp Med 2005, 202:157-168. 10.1084/jem.20050559, 2212905, 15998794.
42. Bu P, Chen KY, Chen JH, Wang L, Walters J, Shin YJ, Goerger JP, Sun J, Witherspoon M, Rakhilin N, Li J, Yang H, Milsom J, Lee S, Zipfel W, Jin MM, Gümüş ZH, Lipkin SM, Shen X. A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells. Cell Stem Cell 2013, 12:602-615. 10.1016/j.stem.2013.03.002, 3646336, 23642368.
43. Sureban SM, May R, Mondalek FG, Qu D, Ponnurangam S, Pantazis P, Anant S, Ramanujam RP, Houchen CW. Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism. J Nanobiotechnology 2011, 9:40. 10.1186/1477-3155-9-40, 3200989, 21929751.
44. Ning L, Wentworth L, Chen H, Weber SM. Down-regulation of Notch1 signaling inhibits tumor growth in human hepatocellular carcinoma. Am J Transl Res 2009, 1:358-366. 2780034, 19956448.
45. Tanaka M, Setoguchi T, Hirotsu M, Gao H, Sasaki H, Matsunoshita Y, Komiya S. Inhibition of Notch pathway prevents osteosarcoma growth by cell cycle regulation. Br J Cancer 2009, 100:1957-1965. 10.1038/sj.bjc.6605060, 2714252, 19455146.
46. Wu X, Weng L, Li X, Guo C, Pal SK, Jin JM, Li Y, Nelson RA, Mu B, Onami SH, Wu JJ, Ruel NH, Wilczynski SP, Gao H, Covarrubias M, Figlin RA, Weiss LM, Wu H. Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis. PLoS One 2012, 7:e35661. 10.1371/journal.pone.0035661, 3356334, 22623952.